Developer of healthcare technology designed to improve health equity by expanding access to cancer precision medicine. The company recognizes inclusive research environments can answer questions that improve health outcomes for all and are committed to transforming the standard of care by addressing inequities in discovery.
Currently, there are no issues on this topic.